Johannes Coetzee, MD
Foot and Ankle Surgery · Edina, MNNPI 1891729000
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (37.4%), ownership interests and other — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Paragon 28, Inc. at 35.4% of the total. Reporting peaked in 2020 at $2,031,483 and has fallen 90.3% since, to $198,013 in 2025. Among foot and ankle surgery clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 428 payments — averaging $10,903 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$1.7M
- Johnson & Johnson$1M
- Depuy Synthes Products, Inc.$618K
- Arthrex$571K
- Smith+Nephew$548K
- Integra Lifesciences Corporation$221K
- plus $47K from 12 others
Across 25 payments — averaging $3230.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$58K
- Medtronic$23K
Across 11 payments — averaging $55,408 each. An ownership or investment interest held by the physician or an immediate family member.
- Responsive Arthroscopy Inc$609K
- Paragon 28, Inc.$0
- Crossroads Extremity Systems, LLC$0
What the payments were for
- Royalty or licence$1,743,14837%
- Consulting fees$125,3203%
- Speaking & faculty fees$111,7672%
- Travel & lodging$18,0390%
- Food & beverage$6,9690%
- Education$1,5790%
- Ownership interest$1,650,00035%
- Other$1,009,63622%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 8 | $1,651,413 |
| Johnson & Johnson | 3 | $1,009,693 |
| Depuy Synthes Products, Inc. | 36 | $617,887 |
| Arthrex | 149 | $571,286 |
| Smith+Nephew | 87 | $548,418 |
| Integra Lifesciences Corporation | 38 | $221,256 |
| Responsive Arthroscopy Inc | 16 | $10,175 |
| Stryker(2 entities) | 33 | $8,989 |
| Medical Device Business Services, Inc. | 2 | $7,920 |
| Zimmer Biomet | 22 | $7,594 |
| Medtronic | 7 | $4,896 |
| Novastep Inc. | 4 | $4,538 |
| Gemini Medical LLC | 6 | $1,843 |
| Foundation Medical, LLC | 5 | $285 |
| Orthofix Medical, Inc. | 9 | $113 |
| Crossroads Extremity Systems, LLC | 1 | $67 |
| Medartis Inc. | 1 | $66 |
| Convatec Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARTHREX$1,408,213
- SALTO TALARIS TOTAL ANKLE PROSTHESIS$394,366
- Integra XT$274,672
- DISTAL EXTREMITIES IMPLANTS MIDFOOT PLATES & SCREWS CFS$128,259
- DISTAL EXTREMITIES IMPLANTS HINDFOOT & ANKLE ANKLE FUSION$117,652
- DISTAL EXTREMITIES INSTRUMENTS DEVICE SPECIFIC INSTRUMENTS HINDFOOT & ANKLE$115,912
- DISTAL EXTREMITIES INSTRUMENTS DEVICE SPECIFIC INSTRUMENTS SCREWS$115,912
- DISTAL EXTREMITIES IMPLANTS MIDFOOT PLATES & SCREWS MIDFOOT SCREWS$115,912
- XT Revision$77,146
- Cadence$45,249
- HAMMERLOCK$35,584
- DISTAL EXTREMITIES IMPLANTS FOOT & ANKLE ANKLE FUSION$31,013
- DISTAL EXTREMITIES INSTRUMENTS FOOT & ANKLE HINDFOOT & ANKLE$31,013
- DISTAL EXTREMITIES IMPLANTS FOOT & ANKLE CFS$31,013
- DISTAL EXTREMITIES IMPLANTS TRAUMA MIDFOOT SCREWS$31,013
- DISTAL EXTREMITIES INSTRUMENTS FOOT & ANKLE SCREWS$18,667
- CADENCE ANKLE REPLACEMENT SYSTEM$17,068
- PANTA NAIL$17,068
- TOTAL FOOT SYSTEM$17,068
- Panta 2$13,879
How this compares
$4,666,458 in reported general payments places this provider in the 95th percentile of 102 foot and ankle surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 28 | $362 |
| Meloxicam | 22 | $215 |
| Cephalexin | 20 | $118 |
| Amoxicillin | 13 | $10 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Edina
- Jeffrey SeyboldEdina$270K
- Long leEdina$17K
- Joseph BellamyEdina$8K
- Jackie Pham HaEdina$3K
- Troy BoffeliSaint Paul$1.7M
- Kyle AbbenSt Louis Park$130K
- Collin MesserlySaint Paul$50K
- Ryan ReinkingDuluth$48K
- Kevin MahoneyMarshall$39K
- Bethany StaehnkeCrookston$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.